InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Stetz Gary S.. Director active across 2 companies, notably Canton Strategic Holdings, Inc.. In total, 10 filings have been logged. Split: 2 buys · 8 sells. Total volume traded: €425k. Activity tracked since 21 April 2026. The latest transaction was disclosed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Stetz Gary S. has 10 filings in total. Across the 10 sampled recent filings, buy amounts are EUR 129274 and sell amounts are EUR 295861, covering the period from 2026-04-27 to 2026-08-12. He is a Director of Canton Strategic Holdings, Inc. and Interim CEO of Hepion Pharmaceuticals, Inc.